Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Spatiotemporal evolution of AML immune microenvironment remodeling and RNF149-driven drug resistance through single-cell multidimensional analysis

Fig. 2

Heterogeneity in acute myeloid leukemia (AML) cells. A Marker gene profiles across distinct AML progenitor cell types; B Five main AML progenitor cell subgroups identified via UMAP analysis; C Expression heatmap and GO analysis for DEGs in the five AML progenitor subclusters; D Scatter plot comparing DEGs in post-chemotherapy remission AML cells to those not achieving remission

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us